164 related articles for article (PubMed ID: 16699961)
1. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.
O'Connor K; Gill C; Tacke M; Rehmann FJ; Strohfeldt K; Sweeney N; Fitzpatrick JM; Watson RW
Apoptosis; 2006 Jul; 11(7):1205-14. PubMed ID: 16699961
[TBL] [Abstract][Full Text] [Related]
2. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
Li L; Zhu Z; Joshi B; Porter AT; Tang DG
Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity and cell death pathways invoked by two new rhodium-ferrocene complexes in benign and malignant prostatic cell lines.
Weber B; Serafin A; Michie J; Van Rensburg C; Swarts JC; Bohm L
Anticancer Res; 2004; 24(2B):763-70. PubMed ID: 15161024
[TBL] [Abstract][Full Text] [Related]
4. Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells.
Morrissey C; O'Neill A; Spengler B; Christoffel V; Fitzpatrick JM; Watson RW
Prostate; 2005 May; 63(2):131-42. PubMed ID: 15486995
[TBL] [Abstract][Full Text] [Related]
5. Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in cervical cancer cells.
Padilla LA; Leung BS; Carson LF
Gynecol Oncol; 2002 Apr; 85(1):59-66. PubMed ID: 11925121
[TBL] [Abstract][Full Text] [Related]
6. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
[TBL] [Abstract][Full Text] [Related]
7. Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement.
Clarke DM; Baust JM; Van Buskirk RG; Baust JG
Cryobiology; 2004 Aug; 49(1):45-61. PubMed ID: 15265716
[TBL] [Abstract][Full Text] [Related]
8. Trk receptor inhibition induces apoptosis of proliferating but not quiescent human osteoblasts.
Pinski J; Weeraratna A; Uzgare AR; Arnold JT; Denmeade SR; Isaacs JT
Cancer Res; 2002 Feb; 62(4):986-9. PubMed ID: 11861369
[TBL] [Abstract][Full Text] [Related]
9. Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells.
Gupta S; Afaq F; Mukhtar H
Biochem Biophys Res Commun; 2001 Oct; 287(4):914-20. PubMed ID: 11573952
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis-inducing vanadocene compounds against human testicular cancer.
Ghosh P; D'Cruz OJ; Narla RK; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1536-45. PubMed ID: 10778987
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin inhibits the expression of X-linked inhibitor of apoptosis protein in human LNCaP cells.
Nomura T; Mimata H; Yamasaki M; Nomura Y
Urol Oncol; 2004; 22(6):453-60. PubMed ID: 15610860
[TBL] [Abstract][Full Text] [Related]
12. TNF receptor 1 is involved in the induction of apoptosis by the cyclin dependent kinase inhibitor p27Kip1 in the prostate cancer cell line PC-3.
Jaruga-Killeen E; Rayford W
FASEB J; 2005 Jan; 19(1):139-41. PubMed ID: 15545300
[TBL] [Abstract][Full Text] [Related]
13. Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis.
Orlandi L; Binda M; Folini M; Bearzatto A; Villa R; Daidone MG; Zaffaroni N
Prostate; 2003 Feb; 54(2):133-43. PubMed ID: 12497586
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis and clonogenic cell death in PC3 human prostate cancer cells after treatment with gamma radiation and suramin.
Palayoor ST; Bump EA; Teicher BA; Coleman CN
Radiat Res; 1997 Aug; 148(2):105-14. PubMed ID: 9254728
[TBL] [Abstract][Full Text] [Related]
15. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
[TBL] [Abstract][Full Text] [Related]
16. Cryosurgery--a putative approach to molecular-based optimization.
Baust JG; Gage AA; Clarke D; Baust JM; Van Buskirk R
Cryobiology; 2004 Apr; 48(2):190-204. PubMed ID: 15094094
[TBL] [Abstract][Full Text] [Related]
17. Different apoptotic mechanisms are involved in the antiproliferative effects of 7beta-hydroxysitosterol and 7beta-hydroxycholesterol in human colon cancer cells.
Roussi S; Winter A; Gosse F; Werner D; Zhang X; Marchioni E; Geoffroy P; Miesch M; Raul F
Cell Death Differ; 2005 Feb; 12(2):128-35. PubMed ID: 15550935
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
Köpf-Maier P
Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
[TBL] [Abstract][Full Text] [Related]
19. Anti-proliferative activity and mechanism of action of titanocene dichloride.
Christodoulou CV; Eliopoulos AG; Young LS; Hodgkins L; Ferry DR; Kerr DJ
Br J Cancer; 1998 Jun; 77(12):2088-97. PubMed ID: 9649119
[TBL] [Abstract][Full Text] [Related]
20. Influence of a novel platinum compound--cis-dichloro (dimethylsulphoxide) (1-beta-D-rybofuranosyl-1,2,4-triazolo-3-arboxyamide) platinum (II)--"Pt-rib-1"--on cell cycle and apoptosis in ClS91 and B16 mouse melanoma in vitro.
Drewa T; Olszewska-Słonina D; Woźniak A; Styczyński J; Drewa G; Szłyk E; Lakomska I; Kobe J; Czajkowski R
Acta Pol Pharm; 2004; 61(1):39-44. PubMed ID: 15259856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
